SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-041246
Filing Date
2023-04-04
Accepted
2023-04-04 08:53:30
Documents
6
Effectiveness Date
2023-04-04

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm2310991d1_s8.htm S-8 67077
2 EXHIBIT 5.1 tm2310991d1_ex5-1.htm EX-5.1 12525
3 EXHIBIT 23.1 tm2310991d1_ex23-1.htm EX-23.1 1994
4 EXHIBIT 23.2 tm2310991d1_ex23-2.htm EX-23.2 2347
5 EX-FILING FEES tm2310991d1_ex-filingfees.htm EX-FILING FEES 18972
6 GRAPHIC tm2310991d1_ex5-1img01.jpg GRAPHIC 4511
  Complete submission text file 0001104659-23-041246.txt   110509
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: PA | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-271103 | Film No.: 23795247
SIC: 2834 Pharmaceutical Preparations